|
When Molecular Data and Clinical Disease Don’t Match: A Case-Based Approach to Transplant Timing/Inherited Platelet Disorders in Disguise: Evaluating Mild Thrombocytopenia and Epistaxis |
03/18/2026 - 8:00am to 9:00am EDT |
|
Treatment of ALL in Young Adults: Current Status? Where are We Going? |
03/25/2026 - 8:00am to 9:00am EDT |
|
Common Medications that Influence Immunotherapy Response in Solid Tumors |
04/01/2026 - 8:00am to 9:00am EDT |
|
From Epidemiology to Immunology: Androgen-Driven Immune Remodeling as a Barrier to HCC Immunotherapy |
04/08/2026 - 8:00am to 9:00am EDT |
|
Autoimmune Lymphoproliferative Syndrome (ALPS) & Born this way: the prevalence, penetrance and prognosis of germline EGFR mutation carriers |
04/15/2026 - 8:00am to 9:00am EDT |
|
Blood Based Tests for Cancer Screening Opportunities and Obstacles |
04/22/2026 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2026 |
04/29/2026 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2026 |
05/06/2026 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2026 |
05/13/2026 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2026 |
05/20/2026 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward